8
Oct
2024

Medsyn (Chengdu) Biotechnology Co., Ltd

Exhibitor at CPHI Milan 2024 stand 4G21, API
About Us

Medsyn Biotechnology Co., Ltd. is a biopharmaceutical company driven by research and innovation. Company's core business is to provide Small-molecule Intermediates,API techpack,PROTAC E3 and linkers.Company has two R&D centers with UPLC-MS,UPLC,HPLCs and 3 Doctors, 8 Masters.We also have two manufacturer sites in China which can ensure the stable supply from grams to tons.The main indications we are focus are Weight loss and Type 2 diabetes,Anti-cancer,Antithrombosis,Sedative.

Read more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
View company profile
Contact info
  • 86-15121117545
  • 5th Floor.Block B., No.5.South Keyuan Rd., 610093, Chengdu, Sichuan, China
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4G21, API

Products Featured at CPHI Milan 2024

  • Orforglipron

    Product Orforglipron

    Obesity is a major risk factor for many leading causes of illness and death worldwide. Data are needed regarding the efficacy and safety of the nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron as a once-daily oral therapy for weight reduction in adults with obesity.In this phase 2, ...
  • SUZETRIGINE

    Product SUZETRIGINE

    Suzetrigine（VX-548） is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.As compared with placebo, VX-548 at the highest dose (a 100-mg oral loading dose of VX-548, followed by a 50-mg maintenance dose every 12 hours...